评估塞内加尔临床医生对真菌感染(真菌病)的知识和经验

IF 2.2 4区 医学 Q3 MYCOLOGY Journal de mycologie medicale Pub Date : 2023-08-01 DOI:10.1016/j.mycmed.2023.101408
Khadim Diongue , Boubou Dembélé , Mouhamadou Ndiaye , Mame Cheikh Seck , Mamadou Alpha Diallo , Aïda Sadikh Badiane , Daouda Ndiaye , Stéphane Ranque
{"title":"评估塞内加尔临床医生对真菌感染(真菌病)的知识和经验","authors":"Khadim Diongue ,&nbsp;Boubou Dembélé ,&nbsp;Mouhamadou Ndiaye ,&nbsp;Mame Cheikh Seck ,&nbsp;Mamadou Alpha Diallo ,&nbsp;Aïda Sadikh Badiane ,&nbsp;Daouda Ndiaye ,&nbsp;Stéphane Ranque","doi":"10.1016/j.mycmed.2023.101408","DOIUrl":null,"url":null,"abstract":"<div><p><span>In order to assess the knowledge and experience of fungal infections<span><span> (FIs) among clinicians in Senegal, a cross-sectional survey was carried out among medical practitioners in Senegal via a questionnaire designed with “Google Forms” between 24 January and 24 April 2022. A total of 100 clinicians responded to the questionnaire. Clinicians in the 31– 40-year-old age group formed the majority of respondents (51%). Male respondents were predominant (72%). Forty-one percent of respondents were general practitioners, 40% were specialist doctors, and the rest were residents. Dermatologists were the most common at 15% (6/40). In terms of clinicians’ general knowledge of fungi, FIs and their therapeutic management, an average of 70% correct answers was recorded. The majority (70%) of respondents cared for between two to four different categories of patients at risk of invasive FIs (IFIs) at a time, with diabetes predominating. Eighty percent confirmed that they had been confronted with FIs, including 43% with superficial FIs, 3% with subcutaneous FIs and 5% with IFIs. Thirty-four percent of doctors stated that they had never suspected an IFI. </span>Candidiasis<span><span> was the most commonly mentioned mycosis by doctors. To support the diagnosis of these FIs, 22% of the clinicians said that they had recourse only to the clinical diagnosis. In total, 79% of clinicians responded that they had never used an antifungal </span>chemoprophylaxis. In addition, 28% and 22% of practicing physicians chose a combination of antifungals for the chemoprophylaxis of </span></span></span>invasive candidiasis<span> and invasive aspergillosis, respectively. This survey shows that both clinicians’ knowledge and experience of fungi, antifungals, FIs and their therapeutic management, as well as chemoprophylaxis, need to be improved. Indeed, half of the clinicians seem to be unaware of the incidence of FIs, in particular IFIs, which, nevertheless, represent some of the deadliest infectious diseases in the world.</span></p></div>","PeriodicalId":14824,"journal":{"name":"Journal de mycologie medicale","volume":null,"pages":null},"PeriodicalIF":2.2000,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Evaluation of knowledge and experience of fungal infections (mycoses) among clinical doctors in Senegal\",\"authors\":\"Khadim Diongue ,&nbsp;Boubou Dembélé ,&nbsp;Mouhamadou Ndiaye ,&nbsp;Mame Cheikh Seck ,&nbsp;Mamadou Alpha Diallo ,&nbsp;Aïda Sadikh Badiane ,&nbsp;Daouda Ndiaye ,&nbsp;Stéphane Ranque\",\"doi\":\"10.1016/j.mycmed.2023.101408\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p><span>In order to assess the knowledge and experience of fungal infections<span><span> (FIs) among clinicians in Senegal, a cross-sectional survey was carried out among medical practitioners in Senegal via a questionnaire designed with “Google Forms” between 24 January and 24 April 2022. A total of 100 clinicians responded to the questionnaire. Clinicians in the 31– 40-year-old age group formed the majority of respondents (51%). Male respondents were predominant (72%). Forty-one percent of respondents were general practitioners, 40% were specialist doctors, and the rest were residents. Dermatologists were the most common at 15% (6/40). In terms of clinicians’ general knowledge of fungi, FIs and their therapeutic management, an average of 70% correct answers was recorded. The majority (70%) of respondents cared for between two to four different categories of patients at risk of invasive FIs (IFIs) at a time, with diabetes predominating. Eighty percent confirmed that they had been confronted with FIs, including 43% with superficial FIs, 3% with subcutaneous FIs and 5% with IFIs. Thirty-four percent of doctors stated that they had never suspected an IFI. </span>Candidiasis<span><span> was the most commonly mentioned mycosis by doctors. To support the diagnosis of these FIs, 22% of the clinicians said that they had recourse only to the clinical diagnosis. In total, 79% of clinicians responded that they had never used an antifungal </span>chemoprophylaxis. In addition, 28% and 22% of practicing physicians chose a combination of antifungals for the chemoprophylaxis of </span></span></span>invasive candidiasis<span> and invasive aspergillosis, respectively. This survey shows that both clinicians’ knowledge and experience of fungi, antifungals, FIs and their therapeutic management, as well as chemoprophylaxis, need to be improved. Indeed, half of the clinicians seem to be unaware of the incidence of FIs, in particular IFIs, which, nevertheless, represent some of the deadliest infectious diseases in the world.</span></p></div>\",\"PeriodicalId\":14824,\"journal\":{\"name\":\"Journal de mycologie medicale\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":2.2000,\"publicationDate\":\"2023-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal de mycologie medicale\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1156523323000525\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"MYCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal de mycologie medicale","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1156523323000525","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MYCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

为了评估塞内加尔临床医生对真菌感染(fi)的知识和经验,在2022年1月24日至4月24日期间,通过使用“谷歌表格”设计的问卷,对塞内加尔的医生进行了横断面调查。共有100名临床医生回答了问卷。31 - 40岁年龄组的临床医生占应答者的大多数(51%)。男性受访者占多数(72%)。41%的受访者是全科医生,40%是专科医生,其余是住院医生。皮肤科医生是最常见的,占15%(6/40)。在临床医生对真菌、fi及其治疗管理的一般知识方面,平均答对率为70%。大多数应答者(70%)一次照顾两到四种不同类型的有侵袭性fi风险的患者,其中以糖尿病为主。80%的人证实他们曾遇到过金融机构感染,其中43%为浅表金融机构感染,3%为皮下金融机构感染,5%为金融机构感染。34%的医生表示,他们从未怀疑过IFI。念珠菌病是医生最常提到的真菌病。为了支持这些FIs的诊断,22%的临床医生说他们只能求助于临床诊断。总的来说,79%的临床医生表示他们从未使用过抗真菌化学预防药物。此外,28%和22%的执业医生分别选择抗真菌药物联合用于侵袭性念珠菌病和侵袭性曲霉病的化学预防。这项调查显示,临床医生对真菌、抗真菌药物、FIs及其治疗管理和化学预防的知识和经验都需要提高。事实上,一半的临床医生似乎不知道金融机构的发病率,特别是金融机构的发病率,尽管这些疾病是世界上最致命的传染病之一。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Evaluation of knowledge and experience of fungal infections (mycoses) among clinical doctors in Senegal

In order to assess the knowledge and experience of fungal infections (FIs) among clinicians in Senegal, a cross-sectional survey was carried out among medical practitioners in Senegal via a questionnaire designed with “Google Forms” between 24 January and 24 April 2022. A total of 100 clinicians responded to the questionnaire. Clinicians in the 31– 40-year-old age group formed the majority of respondents (51%). Male respondents were predominant (72%). Forty-one percent of respondents were general practitioners, 40% were specialist doctors, and the rest were residents. Dermatologists were the most common at 15% (6/40). In terms of clinicians’ general knowledge of fungi, FIs and their therapeutic management, an average of 70% correct answers was recorded. The majority (70%) of respondents cared for between two to four different categories of patients at risk of invasive FIs (IFIs) at a time, with diabetes predominating. Eighty percent confirmed that they had been confronted with FIs, including 43% with superficial FIs, 3% with subcutaneous FIs and 5% with IFIs. Thirty-four percent of doctors stated that they had never suspected an IFI. Candidiasis was the most commonly mentioned mycosis by doctors. To support the diagnosis of these FIs, 22% of the clinicians said that they had recourse only to the clinical diagnosis. In total, 79% of clinicians responded that they had never used an antifungal chemoprophylaxis. In addition, 28% and 22% of practicing physicians chose a combination of antifungals for the chemoprophylaxis of invasive candidiasis and invasive aspergillosis, respectively. This survey shows that both clinicians’ knowledge and experience of fungi, antifungals, FIs and their therapeutic management, as well as chemoprophylaxis, need to be improved. Indeed, half of the clinicians seem to be unaware of the incidence of FIs, in particular IFIs, which, nevertheless, represent some of the deadliest infectious diseases in the world.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
5.10
自引率
2.80%
发文量
68
审稿时长
6-12 weeks
期刊介绍: The Journal de Mycologie Medicale / Journal of Medical Mycology (JMM) publishes in English works dealing with human and animal mycology. The subjects treated are focused in particular on clinical, diagnostic, epidemiological, immunological, medical, pathological, preventive or therapeutic aspects of mycoses. Also covered are basic aspects linked primarily with morphology (electronic and photonic microscopy), physiology, biochemistry, cellular and molecular biology, immunochemistry, genetics, taxonomy or phylogeny of pathogenic or opportunistic fungi and actinomycetes in humans or animals. Studies of natural products showing inhibitory activity against pathogenic fungi cannot be considered without chemical characterization and identification of the compounds responsible for the inhibitory activity. JMM publishes (guest) editorials, original articles, reviews (and minireviews), case reports, technical notes, letters to the editor and information. Only clinical cases with real originality (new species, new clinical present action, new geographical localization, etc.), and fully documented (identification methods, results, etc.), will be considered. Under no circumstances does the journal guarantee publication before the editorial board makes its final decision. The journal is indexed in the main international databases and is accessible worldwide through the ScienceDirect and ClinicalKey platforms.
期刊最新文献
Immunotherapy against environmental fungi causing respiratory allergy Rumex japonicus Houtt. Leaves: The chemical composition and anti-fungal activity Prevalence and outcome of candidemia among paediatric cancer patients: A single centre experience from India Cladosporium cladosporioides brain abscess: An enigmatic case Histoplasmosis in cancer patients: A global scoping review (2001–2024)
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1